Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Linsitinib | 0.031623 | uM | 8 | 156.25 | 23.19 | 361.00 | 348.25 | 1.0366 | 1.0185 |
| MCF 10A | Erlotinib | 0.031623 | uM | 8 | 156.25 | 23.19 | 453.00 | 348.25 | 1.3008 | 1.1392 |
| MCF 10A | Erlotinib | 1 | uM | 8 | 156.25 | 23.19 | 76.00 | 348.25 | 0.2182 | 0.3549 |
| MCF 10A | 17-AAG | 0.000302 | uM | 8 | 156.25 | 23.19 | 375.00 | 348.25 | 1.0768 | 1.0382 |
| MCF 10A | Lapatinib | 3.1623 | uM | 8 | 156.25 | 23.19 | 209.00 | 348.25 | 0.6001 | 0.7551 |
| MCF 10A | 17-AAG | 0.31623 | uM | 8 | 156.25 | 23.19 | 35.00 | 348.25 | 0.1005 | 0.1111 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 156.00 | 348.25 | 0.4480 | 0.6286 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 177.00 | 348.25 | 0.5083 | 0.6820 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 281.00 | 348.25 | 0.8069 | 0.8932 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 260.00 | 348.25 | 0.7466 | 0.8559 | |
| MCF 10A | Linsitinib | 1 | uM | 8 | 156.25 | 23.19 | 143.00 | 348.25 | 0.4106 | 0.5927 |
| MCF 10A | Erlotinib | 0.31623 | uM | 8 | 156.25 | 23.19 | 314.00 | 348.25 | 0.9017 | 0.9477 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 494.00 | 348.25 | 1.4185 | 1.1871 | |
| MCF 10A | Linsitinib | 19.9526 | uM | 8 | 156.25 | 23.19 | 71.00 | 348.25 | 0.2039 | 0.3315 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 613.00 | 348.25 | 1.7602 | 1.3113 |
| MCF 10A | Erlotinib | 10 | uM | 8 | 156.25 | 23.19 | 96.00 | 348.25 | 0.2757 | 0.4383 |
| MCF 10A | Erlotinib | 3.1623 | uM | 8 | 156.25 | 23.19 | 71.00 | 348.25 | 0.2039 | 0.3315 |
| MCF 10A | 17-AAG | 0.0031623 | uM | 8 | 156.25 | 23.19 | 264.00 | 348.25 | 0.7581 | 0.8632 |
| MCF 10A | Erlotinib | 0.01 | uM | 8 | 156.25 | 23.19 | 544.00 | 348.25 | 1.5621 | 1.2418 |
| MCF 10A | Linsitinib | 0.01 | uM | 8 | 156.25 | 23.19 | 754.00 | 348.25 | 2.1651 | 1.4370 |
| MCF 10A | 17-AAG | 0.0001 | uM | 8 | 156.25 | 23.19 | 999.00 | 348.25 | 2.8686 | 1.6189 |
| MCF 10A | 17-AAG | 0.01 | uM | 8 | 156.25 | 23.19 | 105.00 | 348.25 | 0.3015 | 0.4717 |
| MCF 10A | Linsitinib | 10 | uM | 8 | 156.25 | 23.19 | 125.00 | 348.25 | 0.3589 | 0.5388 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 422.00 | 348.25 | 1.2118 | 1.1007 | |
| MCF 10A | Lapatinib | 1 | uM | 8 | 156.25 | 23.19 | 487.00 | 348.25 | 1.3984 | 1.1792 |